within Pharmacolibrary.Drugs.S_SensoryOrgans.S01F_MydriaticsAndCycloplegics.S01FB51_PhenylephrineAndKetorolac;

model PhenylephrineAndKetorolac
  extends Pharmacolibrary.Drugs.ATC.S.S01FB51;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>S01FB51</td></tr><td>route:</td><td>intracameral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Phenylephrine and ketorolac is a fixed-combination ophthalmic solution used to maintain pupil dilation (mydriasis), prevent intraoperative miosis during cataract surgery, and reduce postoperative ocular pain. It is currently approved and in use for these indications.</p><h4>Pharmacokinetics</h4><p>No published studies report population pharmacokinetics for the fixed combination product in ophthalmic (intracameral or topical) use for any population; thus, parameters are estimated primarily based on constituent drugs and expected negligible systemic absorption.</p><h4>References</h4><ol><li><p>Pandey, P, et al., &amp; Cheu, RK (2025). Bioanalytical method validation to quantify ketorolac in human vitreous and aqueous via surrogate matrix of human plasma. <i>Future science OA</i> 11(1) 2476866â€“None. DOI:<a href=\"https://doi.org/10.1080/20565623.2025.2476866\">10.1080/20565623.2025.2476866</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40103417/\">https://pubmed.ncbi.nlm.nih.gov/40103417</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end PhenylephrineAndKetorolac;
